157 related articles for article (PubMed ID: 36297368)
1. HBK-10, A Compound with α
Lustyk K; Sałaciak K; Siwek A; Filipek B; Sapa J; Marona H; Żelaszczyk D; Pytka K
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297368
[TBL] [Abstract][Full Text] [Related]
2. Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.
Pytka K; Lustyk K; Żmudzka E; Kotańska M; Siwek A; Zygmunt M; Dziedziczak A; Śniecikowska J; Olczyk A; Gałuszka A; Śmieja J; Waszkielewicz AM; Marona H; Filipek B; Sapa J; Mogilski S
Front Pharmacol; 2016; 7():229. PubMed ID: 27536240
[TBL] [Abstract][Full Text] [Related]
3. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
[TBL] [Abstract][Full Text] [Related]
4. Novel Arylpiperazine Derivatives of Salicylamide with α
Żmudzka E; Lustyk K; Siwek A; Wolak M; Gałuszka A; Jaśkowska J; Kołaczkowski M; Sapa J; Pytka K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613736
[TBL] [Abstract][Full Text] [Related]
5. The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia.
Lustyk K; Sałaciak K; Zaręba P; Siwek A; Sapa J; Pytka K
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832847
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic properties of some 1,4-disubstituted piperazine derivatives with α1-adrenoceptor affinities.
Kubacka M; Mogilski S; Filipek B; Marona H
Eur J Pharmacol; 2013 Nov; 720(1-3):237-46. PubMed ID: 24161912
[TBL] [Abstract][Full Text] [Related]
8. HBK-15, a Multimodal Compound, Showed an Anxiolytic-Like Effect in Rats.
Lustyk K; Sałaciak K; Jakubczyk M; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Marona H; Pytka K
Neurochem Res; 2023 Mar; 48(3):839-845. PubMed ID: 36350432
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT
Sałaciak K; Malikowska-Racia N; Lustyk K; Siwek A; Głuch-Lutwin M; Kazek G; Popiół J; Sapa J; Marona H; Żelaszczyk D; Pytka K
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451841
[TBL] [Abstract][Full Text] [Related]
10. Biofunctional studies of new 2-methoxyphenylpiperazine xanthone derivatives with α₁-adrenolytic properties.
Rapacz A; Sapa J; Nowiński L; Mogilski S; Pytka K; Filipek B; Siwek A; Szkaradek N; Marona H
Pharmacol Rep; 2015 Apr; 67(2):267-74. PubMed ID: 25712649
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic properties of some aroxyethylamine derivatives with adrenolytic activity.
Maciag D; Bednarski M; Filipek B; Pociecha T; Szkaradek N; Marona H
Pharmazie; 2008 Jun; 63(6):480-4. PubMed ID: 18604994
[TBL] [Abstract][Full Text] [Related]
12. The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine.
Kubacka M; Mogilski S; Filipek B; Marona H
Eur J Pharmacol; 2013 Jan; 698(1-3):335-44. PubMed ID: 23117089
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular activity of the chiral xanthone derivatives.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
Kulig K; Spieces C; Sapa J; Caspers C; Filipek B; Malawska B
Pharmacol Rep; 2010; 62(1):68-85. PubMed ID: 20360617
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
Rapacz A; Sapa J; Bednarski M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Sep; 738():14-21. PubMed ID: 24876055
[TBL] [Abstract][Full Text] [Related]
17. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
Filipek B; Sapa J; Malawska B; Kulig K; Antkiewicz-Michaluk L
Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic activity of new 2-methoxyphenylpiperazine xanthone derivatives after ischemia/reperfusion in rats.
Rapacz A; Sapa J; Pytka K; Dudek M; Filipek B; Szkaradek N; Marona H
Pharmacol Rep; 2015 Dec; 67(6):1163-7. PubMed ID: 26481536
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone.
Kubacka M; Szkaradek N; Mogilski S; Pańczyk K; Siwek A; Gryboś A; Filipek B; Żmudzki P; Marona H; Waszkielewicz AM
Bioorg Med Chem; 2018 Jul; 26(13):3773-3784. PubMed ID: 29706529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]